The amount of compensatory sweating depends on the patient, the damage that the white rami communicans incurs, and the amount of cell body reorganization in the spinal cord after surgery.
Other potential complications include inadequate resection of the ganglia, gustatory sweating, pneumothorax, cardiac dysfunction, post-operative pain, and finally Horner’s syndrome secondary to resection of the stellate ganglion.
www.ubcmj.com/pdf/ubcmj_2_1_2010_24-29.pdf

After severing the cervical sympathetic trunk, the cells of the cervical sympathetic ganglion undergo transneuronic degeneration
After severing the sympathetic trunk, the cells of its origin undergo complete disintegration within a year.

http://onlinelibrary.wiley.com/doi/10.1111/j.1439-0442.1967.tb00255.x/abstract

Monday, April 28, 2008

blocking the sympathetic system - treatment for social phobia

The connection between psyche and sympathetic nervous system

Timo Telaranta M.D., Ph.D. and Paivi Pohjavaara M.D., Privatix Clinic, Tampere, Finland

In the central nervous system the arousal requires the brain stem, the thalamus and the cortex, attention is maintained in the right frontal lobe; the formation of memories happens in the medial temporal lobe, certain diencephalic nuclei and the basal forebrain. The amygdala rates the emotions of an experience. The limbic system is the centre of the human drives, their regulation requires an intact frontal cortex. The injury in the frontal lobe impairs the executive functions as motivation and attention. The sympathomedullary system and locus coerulaeus are activated in depression, mania, panic disorder and acute phases of schizophrenia. The autonomic nervous system is one of the most important mediators between the mind and the body. It has two roles in this function: the role in basic metabolic function as in energy storage and release, in the control of exocrine secretion and thus intake, in conservation, loss, and transformation of energy the role in behaviour, where the hypothalamus is involved in alert and defense reactions.

The sympathetic system is defined as an energy consumption system and the parasympathetic system is an energy conserving and balancing force. The sympathomedullary system is activated in various mental disorders. The biopsychosocial model is clearly seen in the social phobia. The "fight or flight " response of the sympathetic system can also be seen in the physical signs of the social phobia when the patient is in the centre of attention. With sympathetic overload the patient starts to fear the triggering situations and avoid them. The need-adaptive approach adjusts treatment plans of socially phobic patients who haven't had any help of medication and psychotherapy. It seems possible to treat their symptoms and cut the vicious circle of social phobia blocking the sympathetic system in the upper thoracic level with a surgical procedure. If a patient with the social phobia hasn't had any help of conventional treatment methods such as medication and psychotherapy, the sympathetic block could be a treatment of choice for them

Psychosurgery

In the early 20th century, a medical treatment for mental illness, first developed by Portuguese neurologist Egas Moniz, involved damaging the pathways connecting the frontal lobe to the limbic system. Frontal lobotomy (sometimes called frontal leucotomy) successfully reduced distress but at the cost of often blunting the subject's emotions, volition and personality. The indiscriminate use of this psychosurgical procedure, combined with the severe side effects and dangerous nature of the operation gained it a bad reputation and the frontal lobotomy has largely died out as a psychiatric treatment.

More precise psychosurgical procedures are still occasionally used, although are now very rare occurrences. They may include procedures such as the anterior capsulotomy (bilateral thermal lesions of the anterior limbs of the internal capsule) or the bilateral cingulotomy.

Poor regulation of dopamine pathways has been associated with schizophrenia

A report from the National Institute of Mental Health says a gene variant that reduces dopamine activity in the prefrontal cortex is related to poorer performance and inefficient functioning of that brain region during working memory tasks, and to slightly increased risk for schizophrenia.

Dopamine-sensitive neurons in the cerebral cortex are found primarily in the frontal lobes. The dopamine system is associated with pleasure, long-term memory, planning and drive. Dopamine tends to limit and select sensory information arriving from the thalamus to the fore-brain. Poor regulation of dopamine pathways has been associated with schizophrenia.

The so-called executive functions of the frontal lobes involve the ability to recognize future consequences resulting from current actions, to choose between good and bad actions (or better and best), override and suppress unacceptable social responses, and determine similarities and differences between things or events.

The frontal lobes also play an important part in retaining longer term memories which are not task-based. These are often memories with associated emotions, derived from input from the brain's limbic system, and modified by the higher frontal lobe centers to generally fit socially acceptable norms (see executive functions above). The frontal lobes have rich neuronal input from both the alert centers in the brain-stem, and from the limbic regions.

Orthostatic Intolerance

The normal response for a change in body position, results in a stabilization to the upright position in approximately sixty seconds. During this process, the normal change in heart rate would include an increase in heart rate of 10 to 15 beats per minute, and an increase in diastolic pressure of 10 mm Hg, with only a slight change in systolic pressure.

For those who are afflicted with Orthostatic Intolerance, there is an excessive increase in heart rate upon standing, resulting in the cardiovascular system working harder to maintain blood pressure and blood flow to the brain.

Upright posture also brings about a neurohumoral response, involving a change in the levels of vasopressin, renin, angiotensin and aldosterone levels - all of which are involved in the regulation of blood pressure.
Additionally, arterial baroreceptors, particularly those in the carotid sinus area, play an important role in the regulation of blood pressure and the response to positional changes. As the heart pumps blood to the body, the left atrium is passively filled with blood as a result of the force exerted by venous blood pressure. The baroreceptors in the left atrium respond, proportionately, to the pressure exerted by this venous blood pressure. Thus, a drop in venous blood pressure will trigger a compensatory response to increase blood pressure.

Any disruption in any of these processes, or their coordination, can result in an inappropriate response to an upright position, and can lead to a series of symptoms.


The symptoms for these conditions may include the following:

Excessive Fatigue
Exercise Intolerance
Recurrent Syncope or Near Syncope
Dizziness
Nausea
Tachycardia
Palpitations
Visual Disturbances
Tremulusness
Weakness - most noticeable in the legs
Chest Discomfort
Shortness of Breath
Mood Swings
Migraines and Other Headaches
Gastrointestinal Problems
National Dysautonomia Research Foundation
http://ndrf.org/orthostat.htm

Sunday, April 27, 2008

dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion

The D2 and D3 receptors vary in certain tissues and species as a result of alternative splicing, and the human D4 receptor gene exhibits extensive polymorphic variation. In the central nervous system, dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion, and affect as well as neuroendocrine secretion. In the periphery, dopamine receptors are present more prominently in kidney, vasculature, and pituitary, where they affect mainly sodium homeostasis, vascular tone, and hormone secretion. Numerous genetic linkage analysis studies have failed so far to reveal unequivocal evidence for the involvement of one of these receptors in the etiology of various central nervous system disorders. However, targeted deletion of several of these dopamine receptor genes in mice should provide valuable information about their physiological functions.



PHYSIOLOGICAL REVIEWS Vol. 78 No. 1 January 1998, pp. 189-225
Copyright ©1998 The American Physiological Society
Dopamine Receptors: From Structure to Function

CRISTINA MISSALE, S. RUSSEL NASH, SUSAN W. ROBINSON, MOHAMED JABER, AND MARC G. CARON

Departments of Cell Biology and Medicine, Howard Hughes Medical Institute Laboratories, Duke University Medical Center, Durham, North Carolina

Changes in dopamine D2 receptors and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned rats

Ishida Y, Kawai K, Magata Y, Takeda R, Hashiguchi H, Abe H, Mukai T, Saji H.

Department of Psychiatry, Miyazaki Medical College, University of Miyazaki, Miyazaki, Japan.

We studied tracer distributions in positron emission tomography of ligands for dopamine D1 receptors ([11C]SCH23390) and D2 receptors ([11C]raclopride) and the dopamine precursor analog 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]FDOPA), as a measurement of presynaptic dopaminergic function, in the brain after 6-hydroxydopamine lesioning of the medial forebrain bundle in rats. The unilateral lesions were confirmed behaviorally by methamphetamine-induced rotation 2 weeks after lesioning, and the brains were analyzed by tissue dissection following an intravenous bolus of each tracer 3 weeks after lesioning. [11C]Raclopride, but not [11C]SCH23390, showed a higher accumulation in the striatum on the lesion side compared with that on the non-lesioned (intact) side. On the other hand, a lower accumulation of [18F]FDOPA was found in the striatum and cerebral cortex on the lesion side. Our studies demonstrate upregulation of dopamine D2 receptors in the striatum and a decrease in FDOPA uptake in both the striatum and cerebral cortex ipsilateral to the 6-hydroxydopamine lesions. Therefore, the combination of a D2 antagonist and FDOPA may provide a potentially useful method for assessing the effects of dopamine depletion in Parkinson's disease. Copyright 2004 S. Karger AG, Basel.

Neurodegener Dis. 2004;1(2-3):109-12.

S - increase in activity of the adrenal gland.

Depletion and recovery of catecholamines in several organs of rats treated with reserpine.

[My paper] Rubén Martínez-Olivares, Iván Villanueva, Radu Racotta, Manuel Piñón
Depto. de Fisiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala s/n. Col. Santo Tomás, DF. CP. 11340, México.

Chemical sympathectomy with reserpine depletes catecholamines in every neuronal or nonneuronal cell producing a nonspecific temporal sympathectomy. After reserpine administration, most of the drug is distributed to tissues based on their blood flow and would then either be metabolized or be reversibly bound in lipid depots from where it might be released. Consequently, reserpine concentration and the catecholamine-depleting effect in the various tissues are expected to differ according to the route of administration. This study was designed to compare the effects of intraperitoneal (i.p.) and subcutaneous (s.c.) administration of reserpine on catecholamine depletion and recovery in the liver, portal vein, and adrenal gland on days 1, 4, and 10 after reserpine dosage. Catecholamine determinations were extended to 25 days after the treatment only in s.c. reserpine-treated rats and adding samples of heart and brown adipose tissue to the testing. I.p. and s.c. reserpine administration had the same norepinephrine-depleting effect in the portal vein and liver but full recovery was present in both tissues only in i.p. reserpine-treated rats. In the adrenal gland, both routes of administration produced the same depleting and recovery effect of norepinephrine and epinephrine concentrations. A significant temporary overshoot in epinephrine levels was observed several days after s.c. reserpine treatment. Except for the liver, reserpine injected s.c. depleted norepinephrine concentrations significantly in all other tissues up to the end of the experiment. Our results suggest that chemical sympathectomy caused by reserpine administered s.c. produces a generalized and prolonged decrease in peripheral sympathetic activity that could be compensated by an increase in activity of the adrenal gland.

Auton Neurosci. 2006 May 22; : 16723281 (P,S,E,B)

partial denervation by lesion of peripheral nerve or by tissue destruction induces a change in peripheral nociceptors, making them excitable

Edward R. Perl*

Department of Cell and Molecular Physiology, CB 7545, University of North Carolina, Chapel Hill, NC 27599

Control of expression of molecular receptors for chemical messengers and modulation of these receptors' activity are now established as ways to alter cellular reaction. This paper extends these mechanisms to the arena of pathological pain by presenting the hypothesis that increased expression of alpha -adrenergic receptors in primary afferent neurons is part of the etiology of pain in classical causalgia. It is argued that partial denervation by lesion of peripheral nerve or by tissue destruction induces a change in peripheral nociceptors, making them excitable by sympathetic activity and adrenergic substances. This excitation is mediated by alpha -adrenergic receptors and has a time course reminiscent of experimental denervation supersensitivity. The change in neuronal phenotype is demonstrable after lesions of mixed nerves or of the sympathetic postganglionic supply. Similar partial denervations also produce a substantial increase in the number of dorsal root ganglion neurons evidencing the presence of alpha -adrenergic receptors. The hypothesis proposes the increased presence of alpha -adrenergic receptors in primary afferent neurons to result from an altered gene expression triggered by cytokines/growth factors produced by disconnection of peripheral nerve fibers from their cell bodies. These additional adrenergic receptors are suggested to make nociceptors and other primary afferent neurons excitable by local or circulating norepinephrine and epinephrine. For central pathways, the adrenergic excitation would be equivalent to that produced by noxious events and would consequently evoke pain. In support, evidence is cited for a form of denervation supersensitivity in causalgia and for increased expression of human alpha -adrenergic receptors after loss of sympathetic activity.

Vol. 96, Issue 14, 7664-7667, July 6, 1999


PNAS
Bendroflumethiazide; Nadolol Tablets

What should my health care professional know before I receive Bendroflumethiazide; Nadolol?

They need to know if you have any of these conditions:

*

asthma, bronchitis or bronchospasm
*

autoimmune disease such as lupus
*

chest pain (angina)
*

circulation problems, or blood vessel disease (such as Raynaud's disease)
*

depression
*

diabetes
*

electrolyte imbalance (such as low or high levels of potassium in the blood)
*

emphysema, COPD, or other lung disease
*

gout
*

heart disease (such as heart failure or a history of heart attack)
*

kidney disease
*

liver disease
*

muscle weakness or myasthenia gravis
*

pancreatitis
*

pheochromocytoma
*

post-sympathectomy
*

psoriasis
*

thyroid disease
*

unusually slow heartbeat

Supersensitivity of effector cells (smooth muscle) occurs following long-term use, reminiscent of surgical sympathectomy.

Guanethidine and guanadrel

Adverse effects and toxicity: Postural hypotension and decreased blood flow to heart and brain. It causes delayed ejaculaiton in men, increased GI motility and diarrhea. Supersensitivity of effector cells (smooth muscle) occurs following long-term use, reminiscent of surgical sympathectomy.

The antihypertensive effects of thiazides may be enhanced in the post-sympathectomy patient.

PRODUCT MONOGRAPH

TENORETIC

Antihypertensive Agent

PRECAUTIONS:

The antihypertensive effects of thiazides may be enhanced in the post-sympathectomy patient.

Posterior Left Thoracic Cardiac Sympathectomy by Surgical Division of the Sympathetic Chain: An Alternative Approach to Treatment of the Long QT Syndr

Although high thoracic left Sympathectomy via art anterior surgical approach is a highly efficacious treatment for refractory ventricular arrhythmias in patients with the long QT syndrome, the degree of sympathetic denervation has been variable, success of the operation is influenced by anatomical differences between patients, and Horner's syndrome may result. We hypothesized that interruption of sympathetic input to the heart could be accomplished using a posterior thoracic approach to this variable and often complex anatomy by division of the sympathetic chain rather than by direct destruction of the stellate and superior thoracic ganglia with the more conventional anterior, supraclavicular approach. In addition, the posterior approach should decrease the risk of Horner's syndrome by avoiding the ocular sympathetic efferent nerves. This posterior approach is described in five patients with the long QT syndrome and recurrent ventricular arrhythmias. After a mean follow-up of 18 ± 12 months, all are alive without Homer's syndrome.

* ANDREW E. EPSTEIN11Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama,
* MICHAEL J. ROSNER,**Division of Neurosurgery, Department of Surgery, The University of Alabama at Birmingham, Birmingham, Alabama
* GILBERT R. HAGEMAN,****Department of Physiology and Biophysics, The University of Alabama at Birmingham, Birmingham, Alabama
* JAMES H. BAKER, II11Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama,
* VANCE J. PLUMB11Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, and
* G. NEAL KAY11Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama

*
1Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama *Division of Neurosurgery, Department of Surgery, The University of Alabama at Birmingham, Birmingham, Alabama **Department of Physiology and Biophysics, The University of Alabama at Birmingham, Birmingham, Alabama

Pindolol - inhibition of ejaculaiton

AccessPharmacy.com
... similar to those of surgical sympathectomy, including inhibition of ejaculation, ..... Daily doses of pindolol start at 10 mg; of acebutolol, at 400 mg; ...
www.accesspharmacy.com/Content.aspx?searchStr=acebutolol&aid=2500340 - 139k - Cached - Similar pages

Potentiation of the antihypertensive effect occurs with ganglionic or peripheral adrenergic blocking drugs and in the post sympathectomy patient

Name of the medicine: BARBLOC
The active ingredient of Barbloc is pindolol.

Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis

神经肽Y及Th1/Th2细胞与多发性硬化Multiple sclerosis, neuropeptide Y ...

- [ Translate this page ]
Multiple sclerosis, neuropeptide Y and Th1/Th2 cell .... Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis 《Journal ...
scholar.ilib.cn/Abstract.aspx?A=xdkf200521094 - Similar pages - Note this


Maintenance of blood pressure is mostly dependent on sympathetic “tone”, and the sympathetic nerve innervates the entire vascular bed

Pharmacology and Physiology of Perivascular Nerves Regulating Vascular Function
Role of Perivascular Sympathetic Nerves and Regional Differences in the Features of Sympathetic Innervation of the Vascular System

Hiromichi Tsuru1), Noriaki Tanimitsu2) and Tomohisa Hirai2)
1) Department of Pharmacology, Toho University School of Medicine
2) Department of Otorhinolaryngology, Hiroshima University School of Medicine
Maintenance of blood pressure is mostly dependent on sympathetic
“tone”, and the sympathetic nerve innervates the entire vascular
bed, excepting the capillaries. Although norepinephrine (NE) is the
principal neurotransmitter released upon sympathetic nerve
stimulation, neuropeptide Y and ATP are cotransmitters in various
vascular tissues. In addition, dopamine and epinephrine, as well as acetylcholine, have been shown to be sympathetic neurotransmitters
in specific vasculatures. Transmitter NE release is modified by a
number of endogenous substances including the transmitter itself.
Chronic denervation of the preganglionic fiber induces an increase
in NE release per pulse, indicating postganglionic neuronal
supersensitivity. So far, three main adrenoceptor types have been
shown, α1, α2 and β, each of which is further divided into at least three subtypes, as well as the α1L-adrenoceptor, a phenotype of the cloned α1a-adrenoceptor, in the blood vessel. Thus, the response of vessels
with different receptor types to a transmitter varies quantitatively
and even qualitatively from one vessel to another. The remarkable
diversity in the sympathetic innervation mechanism in the vascular
system may play an important role in regional variations in the
regulation of blood flow. The sympathetic nerve also exerts
long-term trophic action on the blood vessel. In conclusion, the
sympathetic nervous system plays an important role not only in
the regulation of cardiovascular dynamics but in the maintenance
of the vessel structure, as well.

The Japanese Journal of PharmacologyVol. 88 (2002) ,
No. 1 pp.9-13

The significant fall in left circumflex coronary flow was proportional to the decline in external heart work due to sympathectomy both at rest and und

E. Bassenge1, J. Holtz1, W. v. Restorff1 and K. Oversohl1

(1) Physiologisches Institut der Ludwig-Maximilian-Universität München, Germany

Received: 18 April 1973

The exercise capacity and the increase of coronary and systemic hemodynamics under treadmill exercise were studied in 5 dogs, chemically sympathectomized with 6-hydroxy-dopamine.
Completeness of adrenergic denervation was verified by stimulation of the right stellate ganglion, by intravenous administration of tyramine, and by demonstration of supersensitivity to exogenous norepinephrine.
These dogs demonstrated a retarded adaptation of hemodynamics to a sudden start of exercise. A fall in mean arterial pressure below 45 mmHg within 10 to 15 sec lead to collapse. After a recovery period of 60–90 sec, moderate treadmill exercise could be continued; steady state attainment of hemodynamic parameters was considerably delayed.
A steady state of exercise with an O2-consumption (vO2) of 29.6±2.6 ml/min · kg and a cardiac outupt (CO) of 307±16 ml/min · kg was tolerated for at least 20 min.
An increase of vO2 up to 42.0±1.7 ml/min · kg and of CO up to 357±13 ml/min · kg under exercise was tolerated for 5 min with steady state, maximal heart rate being 160±4 min–1 at this level of exercise.
Mean arterial pressure and total peripheral resistance were significantly reduced at rest and during steady state of exercise as compared to controls prior to sympathectomy identical vO2, whereas CO remained unchanged.
The significant fall in left circumflex coronary flow was proportional to the decline in external heart work due to sympathectomy both at rest and under exercise.

Differential Effects of Chemical Sympathectomy on Expression and Activity of Tyrosine Hydroxylase and Levels of Catecholamines and DOPA

Tyrosine hydroxylase (TH) mRNA and activity and concentrations of 3,4-dihydroxyphenylalanine (DOPA) and catecholamines were examined as markers of sympathetic innervation and catecholamine synthesis in peripheral tissues of sympathectomized and intact rats. Chemical sympathectomy with 6-hydroxydopamine (6-OHDA) markedly decreased norepinephrine and to a generally lesser extent TH activities and dopamine in most peripheral tissues (stomach, lung, testis, duodenum, pancreas, salivary gland, spleen, heart, kidney, thymus). Superior cervical ganglia, adrenals and descending aorta were unaffected and vas deferens showed a large 92% decrease in norepinephrine, but only a small 38% decrease in TH activity after 6-OHDA.

Minoru Kawamura1, 2, Joan P. Schwartz1, Takuo Nomura1, Irwin J. Kopin1, David S. Goldstein1, Thanh-Truc Huynh1, Douglas R. Hooper1, Judith Harvey-White1 and Graeme Eisenhofer1

(1) Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20892
(2) Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co., Ltd. Hyogo, 673-14, Japan
Volume 24, Number 1 / January, 1999
JournalNeurochemical Research

the sympathetic nervous system regulates the clinical and pathological manifestations of experimental autoimmune encephalomyelitis (EAE)

Department of Immunology, National Institute of Neuroscience, NCNP, Ogawahigashi, Kodaira, Tokyo, Japan.

Prior studies have revealed that the sympathetic nervous system regulates the clinical and pathological manifestations of experimental autoimmune encephalomyelitis (EAE), an autoimmune disease model mediated by Th1 T cells. Although the regulatory role of catecholamines has been indicated in the previous works, it remained possible that other sympathetic neurotransmitters like neuropeptide Y (NPY) may also be involved in the regulation of EAE. Here we examined the effect of NPY and NPY receptor subtype-specific compounds on EAE, actively induced with myelin oligodendrocyte glycoprotein 35-55 in C57BL/6 mice. Our results revealed that exogenous NPY as well as NPY Y(1) receptor agonists significantly inhibited the induction of EAE, whereas a Y(5) receptor agonist or a combined treatment of NPY with a Y(1) receptor antagonist did not inhibit signs of EAE. These results indicate that the suppression of EAE by NPY is mediated via Y(1) receptors. Furthermore, treatment with the Y(1) receptor antagonist induced a significantly earlier onset of EAE, indicating a protective role of endogenous NPY in the induction phase of EAE. We also revealed a significant inhibition of myelin oligodendrocyte glycoprotein 35-55-specific Th1 response as well as a Th2 bias of the autoimmune T cells in mice treated with the Y(1) receptor agonist. Ex vivo analysis further demonstrated that autoimmune T cells are directly affected by NPY via Y(1) receptors. Taken together, we conclude that NPY is a potent immunomodulator involved in the regulation of the Th1-mediated autoimmune disease EAE.

J. Immunol. 2003 Oct 1;171 (7):3451-8 14500640 (P,S,E,B) Cited:3

Autonomic innervation of immune organs and neuroimmune modulation.

Autonomic & Autacoid Pharmacology. 23(1):1-25, February 2003.
Mignini, F.; Streccioni, V.; Amenta, F.

Abstract:
Summary: 1 Increasing evidence indicates the occurrence of functional interconnections between immune and nervous systems, although data available on the mechanisms of this bi-directional cross-talking are frequently incomplete and not always focussed on their relevance for neuroimmune modulation.

2 Primary (bone marrow and thymus) and secondary (spleen and lymph nodes) lymphoid organs are supplied with an autonomic (mainly sympathetic) efferent innervation and with an afferent sensory innervation. Anatomical studies have revealed origin, pattern of distribution and targets of nerve fibre populations supplying lymphoid organs.

3 Classic (catecholamines and acetylcholine) and peptide transmitters of neural and non-neural origin are released in the lymphoid microenvironment and contribute to neuroimmune modulation. Neuropeptide Y, substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide represent the neuropeptides most involved in neuroimmune modulation.

4 Immune cells and immune organs express specific receptors for (neuro)transmitters. These receptors have been shown to respond in vivo and/or in vitro to the neural substances and their manipulation can alter immune responses. Changes in immune function can also influence the distribution of nerves and the expression of neural receptors in lymphoid organs.

5 Data on different populations of nerve fibres supplying immune organs and their role in providing a link between nervous and immune systems are reviewed. Anatomical connections between nervous and immune systems represent the structural support of the complex network of immune responses. A detailed knowledge of interactions between nervous and immune systems may represent an important basis for the development of strategies for treating pathologies in which altered neuroimmune cross-talking may be involved.

NPY in the regulation of autoimmune Th1 cells

Substantial evidence indicates a dysfunctional communication between the sympathetic nervous system and the immune system in Th1-mediated autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. In this Opinion, we propose that the sympathetic regulation of immunity is not only mediated by catecholamines but also involves neuropeptide Y (NPY), an additional postganglionic SNS transmitter that is shown to modulate various immunological functions in vitro and in vivo. Based on recent experimental findings, we believe that a more precise understanding of the role of NPY in the regulation of autoimmune Th1 cells will provide novel insights into the neuroimmunological basis of autoimmunity.

Sammy Bedouia, Sachiko Miyakec, Rainer H. Straubb, Stephan von Hörstena and Takashi Yamamurac, E-mail The Corresponding Author

aDepartment of Functional and Applied Anatomy, Medical School of Hannover, 30625 Hannover, Germany

bDepartment of Internal Medicine I, University Hospital Regensburg, 93042 Regensburg, Germany

cDepartment of Immunology, National Institute of Neuroscience, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan


Available online 20 August 2004.

Sympathetic Neurotransmitters in Joint Inflammation

Rainer H. Straub MDCorresponding Author Contact Information, E-mail The Corresponding Author and Peter Härle MD

Laboratory of Neuroendocrinoimmunology, Department of Internal Medicine I, University Hospital Regensburg, FJS-Allee 11, 93042 Regensburg, Germany


Available online 5 January 2005.

This article demonstrates the dual pro- and anti-inflammatory role of the sympathetic nervous system (SNS) in inflammatory joint disease (IJD) by way of distinct adrenoceptors. The dual role of the SNS depends on involved compartments, timing of distinct effector mechanisms during the inflammatory process, availability of respective adrenoceptors on target cells, and an intricate shift from β-to-greek small letter alpha adrenergic signaling in the progressing course of the inflammatory disease (β-to-greek small letter alpha adrenergic shift). Additional critical points for the dual role of the SNS in inflammation are the underlying change of immune effector mechanisms during the process of disease progression and the behavior of sympathetic nerve fibers in inflamed tissue (nerve fiber loss). This is accompanied by a relative lack of anti-inflammatory glucocorticoids in relation to inflammation. In quintessence, in early stages of IJD, the SNS plays a predominantly proinflammatory role, whereas in late stages of the disease the SNS most probably exerts anti-inflammatory effects.

Saturday, April 26, 2008

Does bilateral thoracic sympathectomy predispose to reflex bronchospasm following tracheal intubation?

A 31 year old old non-smoking woman, 60 kg, withouth a history of allergy or asthma was scheduled for left knee arthroscopy. Two months previously she had an uneventful general anesthetic for bilateral thorascopic sympathectomy to treat essential hyperhidrosis.

Immediately following intubation, ventilation became difficult. Chest auscultation revealed bilateral expiratory wheezing associated with decreased air entry and increased airway pressure up to 60 cm H2O. Oxygen saturation, as monitored by pulse oximetry, decreased from 100% to 80%.

The severe bronchospams occured immediately following tracheal intubation, suggesting that it may have been a reflex response which was triggered by instrumentation of the airway under light level of anesthesia.

Sympathectomy results in a decrease of plasma norepinephrine, and parasympathetic predominance which may increase airway resistance.

Thus, patients with essential hyperhidrosis who have undergone bilateral thoracic sympathectomy, may be more liable to develop reflex bronchospams under light levels of anesthesia.

Ahed Zeidan MD
Nazih Nahle MD
Anis Baraka MD FRCA
Sahel General Hospital, American Universisty of Beirut Medical Center

Hypoxaemia is of a major concern during thorascopic sympathectomy

Hypoxaemia is of a major concern during thorascopic sympathectomy. However, the pathophysiology of hypoxaemia and consequent decrease in SpO2 differs between the two anaesthetic techniques. The normal physiological response to massive atelectasis is an increase in pulmonary vascular resistance (hypoxic pulmonary vasoconstriction) with re-routing of blood to well ventilated lung zones and consequent improvement in PaO2. HOWEVER, DURING ENDOBRONCHIAL ANAESTHESIA FOR THORACIC SYMPATHECTOMY THERE IS AN APPARENT FAILURE OF THIS COMPENSATORY MECHANISM. When more then 70% of the lung is atelectatic, compensation by hypoxic pulmonary vasoconstriction appears ineffective. During carbon dioxide insufflation using endobronchial intubation, Hartrey and colleagues reported a decrease in systolic arterial pressure of >20mm Hg in 21% of patients. Similarly we have reported sudden hypotension and bradycardia after injudicious carbon dioxide insufflation. Although extremely rare, sudden cardiac arrest has been reported after left T2-3 sympathetic nerve transection. While the exact pathophysiology of this occurence is unclear, it is postulated that before complete transection of the sympathetic trunk, continuous sympathetic stimulation to the stellate ganglions results in a reduction in the ventricular finrillation threshold, arrhythmia and cosequent cardiac arrest. In an iteresting study of the delayed cardiac effects of T2-$ symtpathectomy, Drott and colleagues demonstrated significantly reduced heart rate at rest, and during both exercise and the recovery phase of exercise. Changes is the electrical axis and shortening of the QT interval have also been reported. Irrespective of the technique used the reported incidence of postoperative pneumpthorax is variable, occuring in 2-15% of cases. In a study by Gothberg, Drott and Claes, postoperative chest x-ray after 1274 procedures, in 602 patients demonstrated that a small apical pneumothroax was a usual occurence. Conclusion: Because of the anaesthetic implications and possible surgical complications, many surgeons are reluctant to perform transthoracic sympathectomy. British Journal of Anaesthesia 1997; 79: 113-119 B. Fredman, D. Olsfanger and R. Jedeikin

Left, but not right, one-lung ventilation causes hypoxemia during endoscopic transthoracic sympathectomy

Anesth Analg 2000;90:28
© 2000 International Anesthesia Research Society


CARDIOVASCULAR ANESTHESIA

Sequential Changes of Arterial Oxygen Tension in the Supine Position During One-Lung Ventilation

Seiji Watanabe, MD, Eiko Noguchi, MD, Shinichi Yamada, MD, Nobuya Hamada, MD, and Tatsuhiko Kano, MD

Department of Anesthesiology, Kurume University School of Medicine, Fukuoka, Japan

Implications: Close observation and prompt counteractions including termination of one-lung ventilation (OLV) are crucial for patients under OLV in the supine position, because life-threatening hypoxemia frequently occurs approximately 10 min after starting OLV, even under 100% oxygen inhalation. The left semilateral decubitus position was as effective as the left lateral decubitus position in avoiding life-threatening hypoxemia during OLV.

Incidence of chest wall paresthesia after needlescopic video-assisted thoracic surgery for palmar hyperhidrosis

Alan D.L. Sihoe, Clement S.K. Cheung, Ho-Kei Lai, Tak-Wai Lee, Kin-Hoi Thung, Anthony P.C. Yim*

Department of Surgery, Division of Cardiothoracic Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China

Received 5 September 2004; received in revised form 28 September 2004; accepted 22 October 2004.

* Corresponding author. Tel.: +86 852 2632 2629; fax: +86 852 2647 8273. (E-mail: yimap@cuhk.edu.hk).

Objective: Chest wall paresthesia is a reported sequela of thoracotomy and Video-Assisted Thoracic Surgery (VATS) which is distinct from wound pain. Although needlescopic VATS confers less post-operative pain and better cosmesis, the incidence of paresthesia after needlescopic VATS has not been quantified. Methods: For homogeneity of the patient cohort, we studied 50 patients who received bilateral needlescopic VATS sympathectomy (T2-T4 excision) for palmar hyperhidrosis using 2 or 3mm instruments during a 36-month period at a single institute. A standard questionnaire was administered by telephone interview, with 34 patents responding (68.0%). The median post-operative observation time was 16.5 months (range: 10–40 months). Collected data were compared with a historical group who received conventional VATS using 10mm ports. Results: Paresthetic discomfort distinguishable from wound pain was described by 17 patients (50.0%). The most common descriptions were of ‘bloating’ (41.2%), ‘pins and needles’ (35.3%), or ‘numbness’ (23.5%) in the chest wall. The paresthesia resolved in less than two months in 12 patients (70.6%), but was still felt for over 12 months in three patients (17.6%). Post-operative paresthesia and pain did not impact on patient satisfaction with the surgery, whereas compensatory hyperhidrosis in 24 patients (70.6%) did (P=0.001). The rates and characteristics of the paresthesia following needlescopic VATS are similar to those observed after conventional VATS. Conclusions: Chest wall paresthesia affects a significant but previously overlooked proportion of patients following needlescopic VATS

The effects of hypoxemia, G-6-PD deficiency and sympathectomy might all add to the development of acute pulmonary edema

Transaxillary endoscopic sympathectomy of thoracic ganglia (T2-T3) has recently gained wider acceptance as the treatment of choice for palmar hyperhidrosis. It requires one-lung ventilation to facilitate the surgery. One-lung ventilation, however, is not without complications, among which acute pulmonary edema has been reported. In this case report, we present a patient with palmar hyperhidrosis complicated by glucose-6-phosphate dehydrogenase (G-6-PD) deficiency, who received bilateral endoscopic sympathectomy under alternate one-lung anesthesia, and developed acute pulmonary edema immediately after recruitment of the successive collapsed lung. The effects of hypoxemia, G-6-PD deficiency and sympathectomy might all add to the development of acute pulmonary edema secondary to reexpansion of each individual lung after alternate one-lung ventilation. The possibilities of the inferred causes are herein discussed.

Source: Acta Anaesthesiologica Scandinavica, Volume 45, Number 1, January 2001

Haemodynamic changes during thoracoscopic surgery

Haemodynamic changes during thoracoscopic surgery: The effects of one-lung ventilation compared with carbon dioxide insufflation.

Main Articles

Anaesthesia. 55(1):10-16, January 2000.
Brock, H. 1; Rieger, R. 2; Gabriel, C. 3; Polz, W. 4; Moosbauer, W. 1; Necek, S. 5

Abstract:
Summary: We investigated the haemodynamic and respiratory effects of one-lung ventilation and carbon dioxide insufflation in 13 adult patients undergoing video-assisted thoracoscopy. Cardiorespiratory variables were determined during carbon dioxide insufflation at intrahemithoracic pressures of 5, 10 and 15 mmHg, and after 5 and 15 min of one-lung ventilation. Carbon dioxide insufflation was associated with a clear deterioration in circulatory function. The cardiac index decreased subsequent to increasing intrathoracic pressures. The mean cardiac index (SD) at pressures of 10 and 15 mmHg was 1.86 (0.39) and 1.52 (0.46), respectively, and may be compared with the reduced venous return consistent with tension pneumothorax. One-lung ventilation did not affect haemodynamic variables but reduced arterial oxygenation indices (PaO2/FIO2) from 424.29 (160.79) after induction of anaesthesia, to 207.72 (125.50) after 5 min and 172.04 (72.03) after 15 min of one-lung ventilation, respectively. The oxygenation index was not influenced by intrahemithoracic carbon dioxide insufflation. One-lung ventilation via a double-lumen endobronchial tube is safe and convenient for video-assisted thoracoscopic surgery. It has no further consequences on haemodynamic variables, whereas the compression of the lung by carbon dioxide insufflation may cause circulatory dysfunction.

one-lung ventilation causes hypoxemia during endoscopic transthoracic sympathectomy

Hypoxemia is an abnormal deficiency in the concentration of oxygen in arterial blood (Mosby's Medical Dictionary). A frequent error is made when the term is used to describe poor tissue diffusion as in hypoxia. It is possible to have a low oxygen content (e.g., due to anaemia) but a high PO2 in arterial blood so incorrect use can lead to confusion.

Journal of Vascular Surgery : Reply - Published by Elsevier

2 Y Katz, E Zisman, S Isserles and B Rosenberg,
Left, but not right, one-lung ventilation causes hypoxemia during endoscopic transthoracic sympathectomy.

ETS sympathetically maintained pain, and vasospastic or ischemic vascular disease

Sympathectomy for Pain and Hyperhidrosis: Based on the Breakfast Seminar of April 24, 2001, at the 69th Annual Meeting of the American Association of Neurological Surgeons, Toronto, Ontario, Canada.

Article

Neurosurgery Quarterly. 12(2):89-99, June 2002.
Wilkinson, Harold A.

Abstract:
Summary: Surgical resections of sympathetic ganglia from the thoracic, splanchnic, and lumbar area have been carried out for more than 100 years. In the past decade, neurosurgeons have become more interested in surgery on the sympathetic nervous system as less invasive techniques have been developed. Percutaneous radiofrequency and video-assisted endoscopic techniques have largely replaced open surgical thoracic sympathectomy. Lumbar and splanchnic sympathetic ablation is commonly done by percutaneous chemical techniques or, occasionally, by radiofrequency ablation, but the open techniques are still widely used. Sympathectomy is most widely employed for pathologic hyperhidrosis (especially the palmar component), sympathetically maintained pain, and vasospastic or ischemic vascular disease. The less invasive techniques are especially attractive for treating the sympathetically mediated cardiac diseases, including Prinzmetal angina, "syndrome X," and congenital long Q-T interval syndrome.

Surgical complications are usually manageable, but deaths have occurred (even with endoscopic techniques).

Endoscopic sympathetic block in the treatment

In this study, endoscopic sympathetic block was useful in reducing the symptoms of
severe social phobia. Although the method is surgical and the effect hence mainly biolog-
ical, the psychological symptoms of social phobia were also significantly reduced. The
results are best if the main symptoms are blushing or palpitation, but even a smaller
reduction in the other symptoms is important if it helps the patient to break his isolation.
Knowledge of the elimination of embarrassing physical symptoms in social situations
helps the patient to expose himself to formerly impossible situations, and success in them
also causes psychological symptoms to subside. But the relief of psychological symp-
toms may also be due to direct a biological effect of the operation on the anxiety-mediat-
ing areas in the nervous system. The only meaningful side effect is compensatory sweat-
ing of the trunk, but not even that is significant when modern surgical method are used.
Clamping is as good as bilateral cauterisation, and the results may be equally good with
unilateral and bilateral clamping, but because there were only eight patients who had
undergone a unilateral clamping procedure, the material is not sufficient to allow definite
conclusions concerning that. The results remain unchanged over time, which shows that
they were not due to a placebo effect. In the future, it is important to compare this treat-
ment to traditional treatment in order to find out its place among the other, officially
approved methods of treating social phobia.

PÄIVI
POHJAVAARA
Faculty of Medicine,
Department of Psychiatry,
University of Oulu
OULU 2004

Friday, April 25, 2008

A qualitative study of the development of social phobia

PÄIVI POHJAVAARA
SOCIAL PHOBIA: AETIOLOGY, COURSE
AND TREATMENT WITH ENDOSCOPIC
SYMPATHETIC BLOCK (ESB)
A qualitative study of the development of social phobia
and its meaning in people's lives and a quantitative study
of ESB as its treatment
Academic Dissertation to be presented with the assent of
the Faculty of Medicine, University of Oulu, for public
discussion in the Väinö Pääkkönen Hall of the Department
of Psychiatry, on December 3rd, 2004, at 12 noon.

Thanks to modern research techniques, we know a lot of the location of attention, emo-
tion and arousal modulation in the brain. Arousal requires involvement of the brain stem,
the thalamus and the cortex, while attention is maintained by the function of the right
frontal lobe (Kaplan & Sadock 1998, Nagahama et al. 2001). The amygdala rates the
emotional importance of an experience, and the limbic system is the centre of human
drives, whose regulation appears to require an intact frontal cortex. Crude emotions are
produced and handled in the midbrain structures and the olfactory cortex, while distinct-
ly human emotions are generated in the cortex (Kaplan & Sadock 1998).

Homeostatic responses mediated by the autonomic
nervous system are achieved by altering the balance between the sympathetic, parasympa-
thetic and different hormonal systems (Mosqueda-Garcia 1996). The most apparent link
between the autonomic and endocrine systems is manifested by the interactions between
the adrenal cortex and the adrenal medulla.

The neuroanatomical circuits, which support fear and anxiety behaviour, are modulated
by a variety of chemical neurotransmitter systems (Charney 2003). These include the
peptidergic neurotransmitters, corticotrophin-releasing hormone (CRH), neuropeptide
Yand substance P, the monoaminergic transmitters, norepinephrine, serotonin and dopam-
ine, and the amino acid transmitters, gamma-aminobutyric acid and glutamate.
The connection between the sympathetic nervous system and the psyche is best seen in
anxiety and especially in social phobia. The observed usefulness of beta-adrenergic antag-
onists in performance phobia supports this hypothesis (Sutherland & Davidson 1995).

There are studies indicating possible supersensitivity of the central serotonin systems in
social phobia and schizophrenia patients (Tancer et al. 1995, Malhotra et al. 1998). It has
been shown using SPECT (Pirker et al. 2000) that, in a solitary case study, the decreased
5-HTT activity of a social phobic patient was normalized by a sympathetic block (Kuikka
et al. 2000). Among the many neurotransmitters implicated in social anxiety disorder, the
complex interactions between the noradrenergic and serotonergic systems and the HPA
axis overlap those found seen in fear and anxiety (Marcin & Nemeroff 2003).

The physical symptoms of social phobia might be treated by blocking the sympathetic
system at the upper thoracic level with a surgical procedure (Crozier 2001, Telaranta
1998). Sympathectomy was first used to treat the exophthalmos of Basedow disease
(Jonnesco 1896) and angina pectoris (Le Riche 1913, Jonnesco 1921) in the late 19th and
early 20th centuries. Its beneficial effect on the treatment of facial sweating was noticed
as early as the 1930s, and its impact on palmar sweating was reported in the 1950s, when
the procedure was already carried out endoscopically (Kux 1954).

Endoscopic sympathicotomy and endoscopic sympathetic block strongly influence typical symptoms of patients with social phobia

Social phobia is an anxiety disorder which causes fear and anxiety in social interaction or performance situations and can in its worst forms be very debilitating. The patients tend to isolate themselves and suffer from comorbid disorders such as depression, other anxiety disorders and drug and alcohol abuse. Traditional treatment methods such as medication and psychotherapy cause improvement in only 50–70% of patients. METHODS: 164 patients who had been suffering from social phobia for at least 5 years and who were resistant to conservative treatment (medication and/or psychotherapy) were enrolled in this open, uncontrolled, prospective follow-up study. 71 patients underwent endoscopic sympathicotomy (cauterisation); 93 underwent endoscopic sympathetic block (clamping) of the T2–T3 ganglia. Severity of psychic and physical symptoms was assessed by a modified version of Davidson’s brief social phobia scale and patients’ satisfaction was evaluated 1, 6, and 12 months postoperatively. RESULTS: Fear of observation, performance anxiety and embarrassment were alleviated and alertness increased. Likewise, palpitations, trembling of hands and heads, blushing and hyperhidrosis were relieved. All changes were statistically significant. Patients’ satisfaction was high and remained stable over time. Gender, age, and education did not influence satisfaction rates. CONCLUSIONS: Endoscopic sympathicotomy and endoscopic sympathetic block strongly influence typical symptoms of patients with social phobia.

JournalEuropean Surgery
Volume 37, Number 3 / June, 2005

http://www.springerlink.com/content/w986882515290647/

Wednesday, April 23, 2008

During Thoracoscopic sympathectomy hypotension occurs frequently.

Background : During Thoracoscopic sympathectomy hypotension occurs frequently. In this study we compared propofol with etomidate as a main anesthetic agent for thoracoscopic sympathectomy by observing intraoperative vital signs, postoperative
recovery
and side effects.
Methods : Thirty adult patients scheduled for both thoracoscopic sympathectomy were allocated to groups P (propofol) or E (etomidate). P-deletion test (PDT) was dome and plasma cortisol level was measured. In group P (n = 16), anesthesia was
induced
with fentanyl 100 μg, propofol target controlled infusion (TCI) and vecuronium. Anesthesia was maintained with N2O (60%)-propofol. MAP, HR and bispectral index were measure before induction, right after positioning, at the beginning of
right
and left sympathectomy. In group E(n = 14), anesthesia was induced and maintained with etomidate instead of propofol. Postoperative recovery was assessed on the basis of modified Aldrete scoring system at 5, 15, 30, 60 minutes postoperatively. PDT
was
performed at 1, 2 hours postoperatively. Plasma cortisol level was measured 2 h and 3 days after operation. Occurrence of myoclonic movement and nausea was recorded.
Results : MAP was lover in group P (P < 0.05). There was no difference between groups in HR, plasma cortisol concentration. The values of BIS, PDT, recovery score of group P were higher than those of group E (P< 0.05). The incidence of nausea was significantly higher in group E (P < 0.05). Conclusions : Etomidate anesthesia provided more stable vital signs during thoracoscopic sympathectomy compared to propofol anesthesia. However, in terms of recovery and nausea, better outcome was suggested in propofol anesthesia.

http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0858220000040040262

Sympathetic regulation of Autoimmune Disease

In animal models of human autoimmune disease, alterations in sympathetic innervation, NE concentration and lymphocyte AR expression have been demonstrated. ....reduced splenic noradrenergic innervation and decreased splenic NE concentration were apparent before the onset os disease symptoms. In myelin basic protein-induced EAE and MS-like disease, a reduction in splenic NE concentration was reported at the time of maximal antigen-induced lymphocyte proliferation and was accompanied by an increase in the density of of splenic lymphocyte beta-AR. In chronic/relapsing EAE (CREAE) induced in rats, splenocyte beta-AR density correlated positively with the severity of CREAE. Removal of noradrenergic innervation by chemical sympathectomy with 6-OHDA enhanced the severity of symptoms in EAE...

Neuropsychiatry

By Randolph B. Schiffer, Stephen M. Rao, Barry S. Fogel
Published 2003
Lippincott Williams
& Wilkins

Alterations in autonomic activity have been reported in RA and MS

Neuropsychiatry

By Randolph B. Schiffer, Stephen M. Rao, Barry S. Fogel

The SNS may elicit different, and often opposing functions at different anatomic sites. Localized denervation of draining lymph nodes, with sparing of the nerves innervating the joint, exacerbated joint pathology, but sympathetic removal of sympathetic input, either by beta-AR blockade or chemical sympathectomy with 6-OHDA or guanethidine reduced arthritic symptoms. These results suggest that noradrenergic innervation of draining lymph nodes inhibits the generation of antigen-specific T cells but promotes inflammation of the joints. A similar complexity was demonstrated after beta-agonist administration. Administration of a high dose of EPI reduced the severity of experimental arthritis by an alpha2-AR-mediated mechanism, but a low dose of EPI exacerbated joint injury. These results indicate that care must be used in manipulating the SNS therapeutically in complex diseases.
The SNS may also influence autoimmune processes in humans. Alterations in autonomic activity have been reported in RA and MS, but it is not known whether these changes are induced in response to disease or whether alterations in the SNS play a role in initiating the disease. In children with juvenile RA, increased sympathetic activity and autonomic hyporesponsiveness were associated with disease exacerbation.

Published 2003
Lippincott Williams
& Wilkins

a possible mechanism for sympathectomy-induced adrenal hypertrophy

Journal of Hypertension. 17(7):933-940, July 1999.
Qiua, Jingxin 1; Nelsona, Sharon H. 1; Spethb, Robert C. 2; Wanga, Donna H. 1,3

Abstract:
Objective: Previous studies indicate that the adrenal gland plays a compensatory role in the maintenance of blood pressure in chemically sympathectomized rats. However, the mechanisms responsible for compensatory adrenal responses are poorly understood. This study examined the regulation of adrenal growth and type 1A, 1B, and type 2 angiotensin II (Ang II) receptor (AT1A, AT1B and AT2) expression in the adrenal gland induced by sympathectomy.

Methods: Five-week-old male Sprague-Dawley rats were treated with either guanethidine (50 mg/kg per day, intraperitoneally) or vehicle for 5 weeks. Norepinephrine and epinephrine levels in the atrium of the heart were measured by high-pressure liquid chromatography. Plasma renin activity was determined by radioimmunoassay. Adrenal AT1 and AT2 receptor density was determined by radioligand binding assay. Adrenal AT1A, AT1B and AT2 mRNA levels were determined by Northern blot analysis.

Results: Norepinephrine and epinephrine levels in the atrium of the heart were decreased 86% (P <>0.05), were increased in guanethidine-treated rats compared with vehicle (P < r =" 0.9," r =" 0.6," r =" 20.01,"> 0.05) expression.

Conclusions: Impairment of the sympathetic nervous system with guanethidine withdraws the normal stimulation of this system on the circulating renin-angiotensin system, but upregulates the expression of adrenal Ang II receptors. Increased expression of adrenal AT2 and AT1A receptors may play an important role in adaptive adrenal hypertrophy and hormonal responses to sympathectomy.

Tuesday, April 22, 2008

Associations between neuropeptide Y nerve terminals and intraparenchymal microvessels in rat and human cerebral cortex

Neuropeptide Y (NPY) can influence local brain perfusion, possibly via direct relationships with the microvascular bed. To evaluate this possibility, the authors quantitatively analyzed by light and electron microscopy the morphological associations between immunostained NPY neuronal elements and intraparenchymal microvessels in the rat and human cerebral cortex. At the light microscopic level in the rat frontoparietal cortex, about 16% of NPY neurons and large proximal processes as well as a subset of nerve terminals not affected by double sympathectomy were associated with penetrating arterioles and local microvessels. In human temporal cortex, a dense network of NPY nerve fibers was observed, many of which approached and/or contacted intracortical vessels. At the ultrastructural level, 14% of NPY axonal varicosities in the rat cerebral cortex were considered perivascular and associated with capillaries (70%) or microarterioles (30%). They were particularly enriched in the immediate vicinity (<0.25 src="http://www3.interscience.wiley.com/giflibrary/12/mgr.gif" align="absbottom" border="0">m) of the microvessels, where the perivascular astrocytic leaflets represented a frequent target. In human cerebral cortex, NPY varicosities were observed in proximity to microvessels corresponding primarily to capillaries. Perivascular NPY varicosities never established synaptic junctions with vascular or astroglial elements. The results show that central NPY nerve terminals associate with microvessels and perivascular astroglial cells in the rat and human cerebral cortex. Thus, NPY released from these nerves could possibly influence (via a parasynaptic mode of action) vascular and/or astrocytic functions depending on the distribution of NPY receptors in these cellular compartments. These results provide morphological support for the effects of NPY on brain perfusion and homeostasis. J. Comp. Neurol. 388:444-453, 1997. © 1997 Wiley-Liss, Inc.
Roger Abounader, Edith Hamel *Laboratory of Cerebrovascular Research, Montreal Neurological Institute, Montréal, Québec H3A 2B4, Canada

clear association between the head pain and the release of the neuropeptide calcitonin gene-related peptide (CGRP)

In support, there is a clear association between the head pain and the release of the neuropeptide calcitonin gene-related peptide (CGRP) from the trigeminovascular system. In cluster headache there is, in addition, release of the parasympathetic neuropeptide vasoactive intestinal peptide (VIP) that is coupled to facial vasomotor symptoms. Triptan administration, activating the 5-HT1B/1D receptors, causes the headache to subside and the levels of neuropeptides to normalise, in part through presynaptic inhibition of the cranial sensory nerves. These data suggest a central role for sensory and parasympathetic mechanisms in the pathophysiology of primary headaches. The positive clinical trial with a CGRP receptor antagonist offers a new promising way of treatment.

Lars Edvinssona, Corresponding Author Contact Information, E-mail The Corresponding Author and Rolf Uddmanb

aDepartment of Internal Medicine, University Hospital, S-221 85 Lund, Sweden

bDepartment of Otorhinolaryngology, Malmö University Hospital, Malmö, Sweden


Accepted 8 September 2004.
Available online 18 November 2004.

Blocks the nerve responsible for narrowing blood vessels

Sympathectomy uses procedures that block or remove the nerve responsible for narrowing blood vessels in the hand.

http://health.nytimes.com/health/guides/disease/scleroderma/treatment-for-raynaud's-phenomenon.html

Review

A 2003 systematic review [1] looked at sympathectomy for facial blushing and the authors concluded:

We did not identify any controlled trials or cohort studies. The evidence about effectiveness, based on three case series, was therefore very limited. The main weakness of these studies was their lack of a comparison group and their resulting inability to exclude a placebo response to surgery. In addition, the methods of assessing outcome were poorly described and not validated, and the range of outcomes assessed was limited. The studies provided very limited evidence that sympathectomy improves blushing. Side effects were common.


A 2007 systematic review [2] of endoscopic thoracic sympathectomy for excessive sweating and facial blushing concluded:

The evidence of the effectiveness of ETS is weak due to a lack of randomized trials. The intervention leads to severe immediate complications in some of the patients, and to persistent side-effects for many of the patients.

http://www.clinicalanswers.nhs.uk/index.cfm?question=6881

Gustatory facial sweating subsequent to upper thoracic sympathectomy

MDShanker Nesathuraia, , MDDavid T. Harveyb and MDStanley W. Schatzc

aDepartment of Physical Medicine and Rehabilitation, McMaster University, Canada

bMcMaster University Clinic, Hamilton Civic Hospitals, Henderson General Division, Canada

cDepartment of Neurosurgery, McMaster University Clinic-Hamilton General Hospital, Hamilton, Ontario, Canada


Received 3 February 1994;
accepted 8 July 1994

Gustatory facial sweating has been described as a consequence of upper thoracic sympathectomy. Patients may also develop compensatory hyperhidrosis, sensory deficits, nipple hypersensitivity, and Horner's syndrome. In this article, we have reviewed three patients with reflex sympathetic dystrophy who developed gustatory facial sweating subsequent to endoscopic T2 and T3 ganglionectomy. This article also discusses the possible mechanisms of gustatory facial sweating.

keyterms: dysesthetic pain, vasomotor instability, hyperhidrosis, denervation supersensitivity.

A dysesthetic syndrome can occur after sympathectomy

Eugenia-Daniela Hord, MD, Instructor, Departments of Anesthesia and Neurology, Massachusetts General Hospital Pain Center, Harvard Medical School

A dysesthetic syndrome can occur after sympathectomy; it usually is transient but sometimes can be persistent.
Chemical sympathectomy is transient and should be used initially for diagnostic purposes to
establish the involvement of SNS and hence inhibition of sympathetic activity (eg, increased limb
temperature or ocular Horner signs) without evidence of sensory somatic blockade (eg,
hypoesthesia to pinprick and cold stimuli).

For chemical sympathectomy, 2 basic techniques are used.
Injections of local anesthetic around sympathetic paravertebral ganglia that project to the
affected body part (sympathetic ganglion block): This will affect all components of the
sympathetic outflow to an extremity (adrenergic vasoconstrictor, cholinergic sudomotor, and adrenergic pilomotor).

Intravenous regional block: This will prevent the release of only norepinephrine from the sympathetic terminals within the region of application (ie, distal to the tourniquet).

Effect of sympathetic denervation on the rate of protein synthesis

Rates of protein synthesis were investigated in skeletal muscles from rats submitted to chemical and surgical sympathectomy. Three models of sympathetic denervation were used: 1) treatment with guanethidine (100 mg·kg-1·day-1 sc); 2) lumbar sympathetic denervation (surgical excision of the second and third lumbar ganglia of the sympathetic chain, from which arises the postganglionic fibers to the skeletal muscles of rat hindlimb); and 3) adrenodemedullation. Protein synthesis was estimated in isolated soleus muscle by the rate of incorporation of [14C]tyrosine (0.1 mM, 0.05 µCi/ml) into total protein. Soleus isolated after 2 and 4 days of chemical sympathectomy or after 3 days of lumbar denervation showed a 17-20% statistically significant decrease in in vitro rates of protein synthesis. These effects were reverted by addition of 10-5 M isoproterenol or epinephrine in vitro. Neither clenbuterol nor isoproterenol (10-7, 10-6, or 10-5 M) in vitro affected the rate of protein synthesis in soleus from normal rats. On the other hand, clenbuterol or epinephrine (10-5 M) increased by 20% the rate of protein synthesis in soleus muscles from adrenodemedullated rats and prevented its decrease in muscles from fasted rats. The data suggest that the sympathetic nervous system stimulates protein synthesis in oxidative muscles, probably through the activation of {beta}2-adrenoceptors, especially in situations of hormonal or nutritional deficiency.
Luiz Carlos C. Navegantes, Neusa M. Z. Resano, Amanda M. Baviera, Renato H. Migliorini, and Isis C. Kettelhut
Am J Physiol Endocrinol Metab 286: E642-E647, 2004

Evaluation of long-term chemical sympathectomy

AJP - Heart and Circulatory Physiology, Vol 238, Issue 4 527-H532, Copyright © 1980 by American Physiological Society

K. Fronek

Administration of 6-hydroxydopamine (6-OHDA) will produce long-term sympathectomy in newborn animals. This investigation was designed to determine whether or not a long-term sympathectomy can be achieved by repeated administration of 6-OHDA in adult rabbits. Chronic treatment with 6-OHDA lowered blood pressure on average of 9 mmHg; the carotid sinus reflex was depressed, in contrast to the pressure response to intravenously administered epinephrine, which was doubled. In a constant-flow hindlimb preparation, the response to norepinephrine (NE) in 6-OHDA-treated rats was 50% larger and lasted 3 times longer. NE uptake in vitro, which is proportional to the number of adrenergic nerve endings, was found to be diminished by 80-85% in aortas from 6-OHDA-treated animals, and the dose-response curve for NE was slightly shifted to the left. The number of ganglionic cells in the superior cervical ganglia in treated animals was decreased by 80%. In conclusion, results from 6-OHDA-treated adult animals were entirely consistent with the effects of long-term sympathectomy.

Effects of 6-hydroxydopamine on dopamine and noradrenaline content

Volume 329, Number 3 / May, 1985

P. Soares-da-Silva1 Contact Information and R. Davidson1

(1) Laboratorio de Farmacologia, Faculdade de Medicina, P-4200 Porto, Portugal

Received: 29 October 1984 Accepted: 27 January 1985

6-OHDA and pargyline plus 6-OHDA induced a parallel decrease of the noradrenaline and dopamine content in the main trunk of the mesenteric artery, femoral artery and heart. In the proximal branches of the mesenteric artery, renal and splenic arteries 6-OHDA selectively reduced noradrenaline (by 50%) without changes in dopamine levels. Previous treatment with pargyline abolished this selectivity and depleted the tissue levels of both noradrenaline and dopamine by 75%.

The present findings suggest: an independent dopamine presence in the proximal branches of the mesenteric artery, renal artery and splenic artery; that noradrenaline and dopamine are in one and the same structure in the heart, femoral artery and the main trunk of the mesenteric artery; the saphenous vein is more resistant to chemical sympathectomy than arterial blood vessels; the changes in plasma catecholamine concentrations are probably related to a compensatory mechanism initiated at the adrenal medulla.

Alteration of antioxidant status following sympathectomy: Differential effects of modified plasma levels of adrenaline and noradrenaline

Molecular and Cellular Biochemistry
Volume 152, Number 1 / November, 1995
Philip M. Toleikis1 and David V. Godin
Department of Pharmacology and Therapeutics, The University of British Columbia, V6T 1Z3 Vancouver, B.C., Canada

Differences between adrenalectomy and 6-OH treatment on antioxidant components are suggestive of differential actions of adrenaline and noradrenaline on tissue antioxidant status which may have important implications under conditions associated with elevations in levels of these catecholamines including chronic stress and myocardial infarction.

Monday, April 21, 2008

Sympathectomy improves skin blood flow at the thermoregulatory but not the nutritive level

These results indicate that in case of lower limb ischemia, sympathectomy improves skin blood flow at the thermoregulatory but not the nutritive level of skin microcirculation. This may be related to the fact that the thermoregulatory vessels are mainly sympathetically controlled, whereas the nutritive capillaries are mainly controlled by local (nonneural) factors.

François M.H. van Dielen1, Harrie A.J.M. Kurvers1, Ruben Dammers1, Mirjam G.A. oude Egbrink2, Dick W. Slaaf3, Jan H.M. Tordoir1 and Peter J.E.H.M. Kitslaar1

(1) Department of General Surgery, Cardiovascular Research Institute Maastricht and University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands, NL
(2) Department of Physiology, Cardiovascular Research Institute Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands, NL
(3) Department of Biophysics, Cardiovascular Research Institute Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands, NL

World Journal of Surgery Volume 22, Number 8 / August, 1998

Imbalance of regional cerebral blood flow

Imbalance of regional cerebral blood flow and oxygen consumption: effect of vascular alpha adrenoceptor blockade.


Neuropharmacology. 1993 Mar;32(3):297-302.
Weiss HR, Sinha AK.

Department of Physiology and Biophysics, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854-5635.

the regulation of cerebrovascular tone

Brain perfusion is tightly coupled to neuronal activity, is commonly used to monitor normal or pathological brain function, and is a direct reflection of the interactions that occur between neuronal signals and blood vessels. Cerebral blood vessels at the surface and within the brain are surrounded by nerve fibers that originate, respectively, from peripheral nerve ganglia and intrinsic brain neurons. Although of different origin and targeting distinct vascular beds, these "perivascular nerves" fulfill similar roles related to cerebrovascular functions, a major one being to regulate their tone and, therein, brain perfusion. This utmost function, which underlies the signals used in functional neuroimaging techniques and which can be jeopardized in pathologies such as Alzheimer's disease, stroke, and migraine headache, is thus regulated at several levels. Recently, new insights into our understanding of how neural input regulate cerebrovascular tone resulted in the rediscovery of the functional "neurovascular unit." These remarkable advances suggest that neuron-driven changes in vascular tone result from interactions that involve all components of the neurovascular unit, transducing neuronal signals into vasomotor responses not only through direct interaction between neurons and vessels but also indirectly via the perivascular astrocytes. Neurovascular coupling is thus determined by chemical signals released from activated perivascular nerves and astrocytes that alter vascular tone to locally adjust perfusion to the spatial and temporal changes in brain activity.
Edith Hamel

Laboratory of Cerebrovascular Research, Montreal Neurological Institute, McGill University, Montréal, Québec, Canada

J Appl Physiol 100: 1059-1064, 2006; doi:10.1152/japplphysiol.00954.2005

Dopaminergic regulation of cerebral cortical microcirculation

Nature Neuroscience 1, 286 - 289 (1998)
doi:10.1038/1099
Leonid S. Krimer1, E. Christopher Muly III2, Graham V. Williams1 & Patricia S. Goldman-Rakic1

1 Section of Neurobiology, Yale University School of Medicine, New Haven, Connecticut 06510, USA

2 Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06510, USU

Functional variations in cerebral cortical activity are accompanied by local changes in blood flow, but the mechanisms underlying this physiological coupling are not well understood. Here we report that dopamine, a neurotransmitter normally associated with neuromodulatory actions, may directly affect local cortical blood flow. Using light and electron-microscopic immunocytochemistry, we show that dopaminergic axons innervate the intraparenchymal microvessels. We also provide evidence in an in vitro slice preparation that dopamine produces vasomotor responses in the cortical vasculature. These anatomical and physiological observations reveal a previously unknown source of regulation of the microvasculature by dopamine. The findings may be relevant to the mechanisms underlying changes in blood flow observed in circulatory and neuropsychiatric disorders.

Disturbance of sympathetic cardiovascular regulation is involved in CFS

Wyller VB, Saul JP, Walloe L, Thaulow E "...our results suggest that CFS patients suffer from a more comprehensive disturbance of sympathetic cardiovascular regulation than previously acknowledged, supporting the hypothesis that dysautonomia may be a central etiologic component of CFS (Freeman and Komaroff 1997). Specifically, the sympathetic nervous system is more activated at rest, and seems to have an enhanced response to orthostatic stress, but has a reduced response to the addition of isometric exercise. These abnormalities may account for the high prevalence of orthostatic symptoms among CFS patients.

recent reports have linked cerebral hypoperfusion to abnormalities in cholinergic metabolism

Dr Faisel Khan, Vascular Diseases Research Unit,
University Department of Medicine, Ninewells
Hospital and Medical School, Dundee DD1 9SY, UK

accepted 30 April 2003

Although the aetiology of chronic fatigue syndrome (CFS) is unknown, there have
been a number of reports of blood flow abnormalities within the cerebral circulation
and systemic blood pressure defects manifesting as orthostatic intolerance. Neither
of these phenomena has been explained adequately, but recent reports have linked
cerebral hypoperfusion to abnormalities in cholinergic metabolism. Our group has
previously reported enhanced skin vasodilatation in response to cumulative doses of
transdermally applied acetylcholine (ACh), implying an alteration of peripheral
cholinergic function. To investigate this further, we studied the time course of ACh-
induced vasodilatation following a single dose of ACh in 30 patients with CFS and
30 age- and gender-matched healthy control subjects. No differences in peak blood
flow was seen between patients and controls, but the time taken for the ACh
response to recover to baseline was significantly longer in the CFS patients than in
control subjects. The time taken to decay to 75% of the peak response in patients and
controls was 13Æ7 ± 11Æ3 versus 8Æ9 ± 3Æ7 min (P
1⁄4 0Æ03), respectively, and time
taken to decay to 50% of the peak response was 24Æ5 ± 18Æ8 versus 15Æ1 ± 8Æ9 min
(P
1⁄4 0Æ03), respectively. Prolongation of ACh-induced vasodilatation is suggestive
of a disturbance to cholinergic pathways, perhaps within the vascular endothelium
of patients with CFS, and might be related to some of the unusual vascular
symptoms, such as hypotension and orthostatic intolerance, which are characteristic
of the condition.